Moderna, Inc. — Director's Dealing 2020

Dec 29, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2020-12-28

Reporting Person: Zaks Tal Zvi (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-28	Common Stock	M	1200	$20.93	Acquired	1200	Direct
2020-12-28	Common Stock	S	150	$111.80	Disposed	1050	Direct
2020-12-28	Common Stock	S	60	$113.81	Disposed	990	Direct
2020-12-28	Common Stock	S	185	$115.15	Disposed	805	Direct
2020-12-28	Common Stock	S	180	$116.42	Disposed	625	Direct
2020-12-28	Common Stock	S	375	$117.44	Disposed	250	Direct
2020-12-28	Common Stock	S	250	$118.49	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-28	Stock Option (Right to Buy)	$20.93	M	1200	Disposed	2029-03-08	Common Stock (1200)	Direct

Footnotes

F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $111.34 to $112.12. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $114.89 to $115.49. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $115.93 to $116.83. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $117.01 to $117.99. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $118.11 to $118.85. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.